Eric Schadt, Ph.D., member of GEN’s scientific advisory board.
GEN is honored to welcome Eric Schadt, Ph.D., to its scientific advisory board. Dr. Schadt is director of the Icahn Institute for Genomics and Multiscale Biology, chair of the department of genetics and genomics sciences, and the Jean C. and James W. Crystal Professor of Genomics at the Icahn School of Medicine at Mount Sinai.
Dr. Schadt is an expert on the generation and integration of large-scale sequence variation, molecular profiling, and on clinical data in disease populations for constructing molecular networks that define disease states and link molecular biology to physiology. He is known for calling for a shift in molecular biology toward a network-oriented view of living systems to complement the reductionist, single-gene approaches that currently dominate biology in order to more accurately model the complexity of biological systems.
He has published more than 200 peer-reviewed papers in leading scientific journals, and contributed to a number of discoveries relating to the genetic basis of common human diseases such as diabetes, obesity, and Alzheimer’s disease.
Prior to joining Mount Sinai in 2011, Dr. Schadt held positions at Pacific Biosciences, Rosetta Inpharmatics, and Roche Bioscience. He received his B.A. in applied mathematics and computer science from California Polytechnic State University, his M.A. in pure mathematics from UC-Davis, and his Ph.D. in biomathematics from UCLA (requiring Ph.D. candidacy in molecular biology and mathematics).
“GEN looks forward to Dr. Schadt’s advice and input so that we can continue to provide our readers with the latest information on cutting-edge developments in genomics at both the research and clinical stages,” said John Sterling, editor-in-chief of GEN. “During his four years at the Icahn Institute at Mount Sinai, Dr. Schadt’s presence has added a superior level of expertise to an already established world-class center of excellence of scientific research.”
